Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...

The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...

Novavax's full FDA approval for NUVAXOVID is a transformative milestone, unlocking a $175M Sanofi payment and validating ...